- Remark Media, Inc. stock price today and history
Please, Signup (Login) to subscribe or trade (demo)
Remark Media, Inc. stock price
Remark Media, Inc. latest news:
Netflix shares fall 3% premarket as FAANG, media stocks follow broader market down
Shares of Netflix Inc. were down as much as 3% in premarket trade on Tuesday after dropping roughly 5% on Monday as the broader market continues to sell off. Netflix shares are now down more than 11% from its Jan. 29 intraday high. Other stocks in the FAANG category continued their downward trend in premarket on Tuesday as broader market sank. Facebook Inc. and Amazon.com Inc. were down more than 1%, Apple Inc. was down a little less than 1% and Alphabet Inc. (formerly Google) was down 2%. Some of Netflix's cohorts in the media sector were also struggling in premarket trade. Walt Disney Co. shares were down more than 2%, while shares of Viacom Inc.'s commonly-owned class B shares were down roughly 4% and shares of Discovery Communications Inc. were down more than 3%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Soros says Facebook, Google have become 'obstacles to innovation'
George Soros delivered a strident criticism of two of the world's biggest technology giants: Facebook Inc. and Google Inc., in a Thursday speech. The billionaire investor who runs family office Soros Fund Management said Facebook Inc. and Google are "obstacles to innovation." He said their businesses and social networks would see marginal returns, during a speech in Davos, Switzerland at the World Economic Forum. The remarks from the prominent octogenarian come as Facebook is restructuring its newsfeed and social-media platform in the face of criticisms that platforms like Google and Facebook helped to turn the tide of the 2016 U.S. election in favor of Donald Trump, giving a platform to Russians to influence voters. He said the days of dominance of those tech giants are numbered because of taxation and regulation. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Acorda shares jump 20% premarket on talk of possible takeover by Biogen, other suitors
Shares of biotech Acorda Therapeutics Inc. surged 20% in premarket trade Friday, after media reports that Biogen Inc. and others are eyeing the company as a possible takeover target. The speculation has been swirling for more than a week. On Thursday, the company offered preliminary guidance for 2017 sales of $542 million, an increase of approximately 10% from 2016. The FactSet consensus is for sales of $568 million. Chief Executive Ron Cohen said he expects 2018 to be a transformative year and for the company to achieve approval and launch its Inbrija investigational inhaled levodopa treatment for symptoms of OFF periods in people with Parkinson's disease taking carbidopa/levodopa. Shares have gained 21% in the last 12 months, while the S&P 500 has gained about 24%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Remy International, Inc.REMY
Renewable Energy Group, Inc.REGI
Repros Therapeutics Inc.RPRX
Repros Therapeutics Inc.RPRXW
Repros Therapeutics Inc.RPRXZ